. Author manuscript; available in PMC: 2018 Aug 30.

Published in final edited form as: J Eval Clin Pract. 2014 Jun 11;20(5):638–648. doi: 10.1111/jep.12193

Table 1.

Demographic Characteristics of Patients, Randomized by Physician Practice, Participating in the NSAID¹ Study At Baseline or Follow-up

	Baseline Phase				Follow-up Phase
	Overall % n = 347	Comparison % n = 155	Intervention % n = 192	p	Overall % n = 355	Comparison % n = 180	Intervention % n = 175	p
Black Race	30.26	33.55	27.60	0.231	38.59	30.56	46.86	0.002
Female Sex	74.35	77.42	71.88	0.240	72.11	73.33	70.86	0.603
Mean Age in Years (SD)	74.09 (6.91)	73.91 (7.37)	74.24 (6.54)	0.661	63.48 (9.67)	63.55 (9.29)	63.40 (10.06)	0.877
Some College	33.14	28.39	36.98	0.091	43.66	47.78	39.43	0.113
Adequate Income	73.20	68.39	77.08	0.069	72.68	72.22	68.00	0.051
Medicaid/Uninsured	10.66	14.19	7.81	0.056	18.03	15.56	20.57	0.219
Reported Awareness of Any Prescription NSAID¹ Risk	44.67	47.10	42.71	0.414	55.49	61.11	49.71	0.031
Reported Awareness of Any Over-the-Counter NSAID¹ Risk	25.15 (n = 342)	24.68 (n = 154)	25.53 (n = 188)	0.856	52.97 (n = 353)	56.74 (n = 178)	49.14 (n = 175)	0.153

Nonsteroidal anti-inflammatory Drug (NSAID)